AI 3D imaging system targets 29 medical centers by 2028: IntelliGen

Taipei, Oct. 5 (CNA) An artificial intelligence-powered 3D medical imaging system developed by Taiwanese startup IntelliGen Technology Co. is being tested at the Ministry of Health and Welfare's (MOHW) data center, with the goal of deploying it at all 29 medical centers in Taiwan by 2028, the company's chairman said Monday.

Speaking at the "2026 Taiwan AI 3D Medical Imaging and Metaverse Application Conference," IntelliGen Technology Chairman Sunny Sun (孫繼信) said the company has spent five to six years developing what he described as Taiwan's first domestically developed AI platform for generating 3D medical images.

Developed in collaboration with the MOHW, the platform uses the company's Anatomy Cloud AI technology to convert conventional two-dimensional computed tomography (CT) and magnetic resonance imaging (MRI) scans into high-resolution, full-color 3D anatomical models in three to five minutes, Sun said.

The system can identify and separate more than 260 organs and tissue types while providing physicians with color, grayscale and rendered images for diagnosis, he said.

According to Sun, the web-based platform allows doctors to access 3D images on computers, smartphones and tablets, while also supporting export to mixed-reality headsets for clinical diagnosis and preoperative planning.

He said that, with the platform running on the MOHW's computing infrastructure, it is also aimed at supporting early detection and imaging analysis of common cancers, including lung and liver cancer.

For surgical applications, Sun said the company is applying for a patent on an automatic positioning technology that combines digital twin technology with 3D imaging to align preoperative images with a patient's body, helping surgeons locate lesions and blood vessels with millimeter-level precision.

Looking overseas, Sun said IntelliGen has completed its acquisition of Japanese medical imaging company Holoeyes.

The acquisition combines IntelliGen's AI-based 3D reconstruction technology with Holoeyes' regulatory approvals and distribution network in Japan, enabling the company to expand into operating room applications and access more than 200 leading hospitals and university medical schools in the country.

Sun said the company plans to commercialize the technology through algorithm licensing, white-label manufacturing, software subscription services and joint development of surgical robots, with the goal of shifting Taiwan's medical technology industry from contract manufacturing toward higher-value intellectual property exports.

He said the AI platform will also be made available through MOHW servers to Taiwan's diplomatic allies, allowing healthcare providers to upload medical images for remote analysis while enabling Taiwanese doctors to provide telemedicine support.

Separately, IntelliGen announced plans to seek a listing on Taiwan's Emerging Stock Board in August 2027.

During Monday's conference, the company also donated 10 AI 3D medical imaging workstations to the MOHW for deployment at major medical centers and ministry-affiliated hospitals.

Sun said he hopes Taiwan's medical technology industry can become another globally competitive sector alongside the country's semiconductor industry with continued government support.